You are viewing a free preview of this lesson.
Subscribe to unlock all 12 lessons in this course and every other course on LearningBro.
A gene mutation is a random, spontaneous change in the base sequence of DNA. Because proteins are made by translating mRNA transcripts of genes, a change in DNA sequence can change the sequence of amino acids in a polypeptide, and hence the structure and function of a protein. Mutations are therefore the ultimate source of all genetic variation; without them, evolution by natural selection could not occur. However, most mutations that affect a protein are deleterious or neutral — truly beneficial mutations are rare. OCR A-Level Biology A specification module 6.1.1(a) requires you to understand the types, causes and consequences of gene mutations.
Key Definitions:
- Gene mutation — a change in the base sequence of DNA (strictly speaking, any heritable change at a single locus).
- Point mutation — a mutation affecting a single base (substitution, insertion or deletion of one nucleotide).
- Mutagen — a physical, chemical or biological agent that increases the natural mutation rate.
- Silent mutation — a base change that does not alter the encoded amino acid.
- Missense mutation — a base change that alters one amino acid in the polypeptide.
- Nonsense mutation — a base change that creates a premature stop codon.
- Frameshift mutation — an insertion or deletion (not a multiple of three) that shifts the reading frame.
DNA replication is remarkably accurate — DNA polymerase has a proofreading activity and the post-replication mismatch-repair system removes most errors. Even so, roughly 1 in 10⁹ nucleotides is mis-incorporated per cell division in humans, which over a 3 × 10⁹ bp genome gives a handful of new mutations per cell generation. Mutations arise:
flowchart TB
A[Original DNA: ATG TTC GCA]
A --> B[Substitution: ATG TAC GCA - missense Tyr replaces Phe]
A --> C[Insertion: ATG TTA CGC A - frameshift]
A --> D[Deletion: ATG TCG CA - frameshift]
One base is replaced by another.
Substitutions produce three possible outcomes at the protein level:
| Outcome | Meaning | Example | Effect |
|---|---|---|---|
| Silent | New codon codes for the same amino acid | GAA → GAG (both Glu) | None — degeneracy of the code absorbs the change |
| Missense | New codon codes for a different amino acid | GAG → GTG (Glu → Val) | One amino acid substitution; effect depends on position |
| Nonsense | New codon is a stop codon | CAG → TAG | Premature termination — usually severe |
One or more extra bases are inserted into the sequence. If the number is not a multiple of three, the reading frame shifts downstream of the insertion — a frameshift. Every subsequent codon is changed, and usually a premature stop codon is encountered within a few dozen bases.
One or more bases are removed. Again, a frameshift occurs unless the number removed is a multiple of three. An in-frame deletion of 3 bases removes one amino acid without shifting the frame — the resulting protein may still function partially (e.g. the common ΔF508 deletion in the CFTR gene causes cystic fibrosis by removing a single phenylalanine).
The genetic code is degenerate — most amino acids are encoded by more than one codon, and the "wobble" rules mean that many third-position changes are silent. For example:
| Codon | Amino acid |
|---|---|
| GCU | Ala |
| GCC | Ala |
| GCA | Ala |
| GCG | Ala |
A mutation at the third position of any of these codons does not change the amino acid. This degeneracy acts as a buffer against mutation.
| Disease | Gene | Mutation type | Effect |
|---|---|---|---|
| Sickle-cell anaemia | HBB (β-globin) | Missense (GAG → GTG, Glu6Val) | Hydrophobic valine replaces glutamate, haemoglobin polymerises in low O₂, sickles erythrocytes |
| Cystic fibrosis | CFTR | In-frame 3-bp deletion (ΔF508) | Misfolded CFTR chloride channel is degraded before reaching cell surface |
| Duchenne muscular dystrophy (DMD) | DMD (dystrophin) | Frameshift deletion | Little or no dystrophin protein; progressive muscle wasting |
| Huntington's disease | HTT | Expansion of CAG trinucleotide repeat | Toxic gain of function; polyglutamine tract aggregates in neurons |
| Phenylketonuria (PKU) | PAH | Missense, nonsense or splice site | No functional phenylalanine hydroxylase; Phe accumulates |
Whether a mutation actually changes the phenotype depends on:
Mutations may be beneficial (a new function, e.g. lactase persistence in adult humans), neutral (most silent and many intronic mutations) or deleterious (most amino-acid-changing mutations in essential genes).
Mutagens increase the mutation rate. OCR expects you to know several examples:
Many mutagens are also carcinogens because mutations in proto-oncogenes or tumour suppressor genes can lead to cancer.
Be precise with your language. "A substitution of one base by another" is not the same as "the swapping of an amino acid". The mutation is at the DNA level; its consequence (silent, missense, nonsense) is at the protein level. Always link cause to effect in your answers: "a substitution of A for T in the second base of codon 6 of the β-globin gene changes the codon from GAG to GTG, so the amino acid changes from glutamate to valine, producing haemoglobin S, which polymerises in low-oxygen conditions and distorts erythrocytes into a sickle shape."
Reference: OCR A-Level Biology A (H420) specification 6.1.1(a).